北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 期刊论文
学科主题: 临床医学
题名:
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantation
作者: Mo, Xiao-Dong; Xu, Lan-Ping; Liu, Dai-Hong; Zhang, Xiao-Hui; Chen, Huan; Chen, Yu-Hong; Han, Wei; Wang, Yu; Wang, Feng-Rong; Wang, Jing-Zhi; Liu, Kai-Yan; Huang, Xiao-Jun1,2
刊名: AMERICAN JOURNAL OF HEMATOLOGY
发表日期: 2013-06-01
DOI: 10.1002/ajh.23443
卷: 88, 期:6, 页:497-502
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Hematology
研究领域[WOS]: Hematology
关键词[WOS]: BONE-MARROW-TRANSPLANTATION ; HLA-MISMATCHED/HAPLOIDENTICAL BLOOD ; ACUTE MYELOID-LEUKEMIA ; INSULIN-RESISTANCE ; DISEASE STATUS ; CANCER ; TUMOR ; INFLAMMATION ; MULTICENTER ; MANAGEMENT
英文摘要:

To validate the predictive ability of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) on the outcome of hematopoietic stem cell transplantation (HSCT) patients who received transplants from partially matched related donors (PMRD), a total of 526 patients who received PMRD HSCT between January 2006 and December 2009 at the Institute of Hematology, Peking University were enrolled. Patients were grouped according to their HCT-CI score; 31.0%, 31.4%, and 37.6% of patients had HCT-CI scores of 0, 12, and 3, respectively. Patients with HCT-CI scores of 3 had a significantly poorer 2-year overall survival (OS) than patients with HCT-CI scores of 02 (54.55% vs. 78.05%, P<0.001). In addition, patients with HCT-CI scores of 3 had a significantly higher 2-year cumulative incidence of relapse and nonrelapse mortality (NRM) than patients with scores of 02 (relapse: 23.23% vs. 11.59%, P<0.001; NRM: 34.30% vs. 15.93%, P<0.001). HCT-CI scores of <3 were associated with better OS, less relapse, and lower NRM in multivariate analysis. Patients who had high comorbidity scores as well as high-risk disease had the poorest outcomes. Therefore, we found that HCT-CI is associated with the outcomes of PMRD HSCT and we should closely monitor patients with a high comorbidity burden. Am. J. Hematol. 88:497502, 2013. (c) 2013 Wiley Periodicals, Inc.

语种: 英语
所属项目编号: 2011AA020105 ; 81230013
项目资助者: National High Technology Research and Development Program of China (Program 863) ; Key Program of National Natural Science Foundation of China
WOS记录号: WOS:000319293000009
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/65761
Appears in Collections:北京大学第二临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Peoples Hosp, Beijing 100044, Peoples R China
2.Beijing Key Lab Hematopoiet Stem Cell Transplanta, Inst Hematol, Beijing 100044, Peoples R China

Recommended Citation:
Mo, Xiao-Dong,Xu, Lan-Ping,Liu, Dai-Hong,et al. The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantation[J]. AMERICAN JOURNAL OF HEMATOLOGY,2013,88(6):497-502.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Mo, Xiao-Dong]'s Articles
[Xu, Lan-Ping]'s Articles
[Liu, Dai-Hong]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Mo, Xiao-Dong]‘s Articles
[Xu, Lan-Ping]‘s Articles
[Liu, Dai-Hong]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace